{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:04:25Z","timestamp":1793459065820,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.antiviral.2008.01.003","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T13:22:27Z","timestamp":1202217747000},"page":"91-102","source":"Crossref","is-referenced-by-count":202,"title":["Current and future antiviral therapy of severe seasonal and avian influenza"],"prefix":"10.1016","volume":"78","author":[{"given":"John","family":"Beigel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.01.003_bib1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3201\/eid1007.040415","article-title":"Atypical avian influenza (H5N1)","volume":"10","author":"Apisarnthanarak","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.CCM.0000262940.34596.4B","article-title":"The critically ill avian influenza A (H5N1) patient","volume":"35","author":"Arabi","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib3","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design","volume":"43","author":"Babu","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.003_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2005.10.002","article-title":"Anti-influenza virus activity of peramivir in mice with single intramuscular injection","volume":"69","author":"Bantia","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01314321","article-title":"Replication of avian influenza viruses in humans","volume":"119","author":"Beare","year":"1991","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib6","unstructured":"Beigel, J., Harman, L.A., Collis, P.J., McCullough, A., Kilpatrick., J.M., Ruff, D., Mead, E., Alexander, W.J., 2007. Pharmacokinetic and safety evaluations of escalating doses of peramivir administered intravenously in healthy volunteers. ICAAC 2007, Poster A-1408."},{"key":"10.1016\/j.antiviral.2008.01.003_bib7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMra052211","article-title":"Avian influenza A (H5N1) infection in humans","volume":"353","author":"Beigel","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2008.01.003_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jcv.2007.04.010","article-title":"Influenza A\/H5N1 virus infection in humans in Cambodia","volume":"39","author":"Buchy","year":"2007","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1637\/7594-040306R.1","article-title":"Surveillance activities and molecular analysis of H5N1 highly pathogenic avian influenza viruses from Thailand, 2004\u20132005","volume":"51","author":"Buranathai","year":"2007","journal-title":"Avian Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib12","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JCM.43.11.5760-5767.2005","article-title":"Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003","volume":"43","author":"Butt","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/AAC.43.7.1616","article-title":"Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection","volume":"43","author":"Calfee","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(01)00215-7","article-title":"Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo","volume":"54","author":"Carr","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1099\/jmm.0.47124-0","article-title":"A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza","volume":"56","author":"Carter","year":"2007","journal-title":"J. Med. Microbiol."},{"issue":"Suppl 2","key":"10.1016\/j.antiviral.2008.01.003_bib16","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/338820","article-title":"Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997","volume":"34","author":"Chan","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-6-135","article-title":"Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells","volume":"6","author":"Chan","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib18","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/j.bmc.2005.03.048","article-title":"Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo","volume":"13","author":"Chand","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.003_bib19","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1086\/504723","article-title":"Distribution of amantadine-resistant H5N1 avian influenza variants in Asia","volume":"193","author":"Cheung","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib20","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(02)11772-7","article-title":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?","volume":"360","author":"Cheung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib21","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.ppat.0030141","article-title":"A single mutation in the PB1-F2 of H5N1 (HK\/97) and 1918 influenza A viruses contributes to increased virulence","volume":"3","author":"Conenello","year":"2007","journal-title":"PloS Pathogens"},{"key":"10.1016\/j.antiviral.2008.01.003_bib22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.326.7401.1235","article-title":"Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials","volume":"326","author":"Cooper","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2008.01.003_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/4351009a","article-title":"China's chicken farmers under fire for antiviral abuse","volume":"435","author":"Cyranoski","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.003_bib24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nrd2175","article-title":"Antiviral agents active against influenza A viruses","volume":"5","author":"De Clercq","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2008.01.003_bib25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMoa044307","article-title":"Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma","volume":"352","author":"De Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"De Jong","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib27","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"De Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib28","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/JVI.74.3.1443-1450.2000","article-title":"Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses","volume":"74","author":"Dybing","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.003_bib31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3201\/eid1201.051186","article-title":"Antiviral response in pandemic influenza viruses","volume":"12","author":"Garcia-Sastre","year":"2006","journal-title":"Emerg. Infect. Dis."},{"issue":"23","key":"10.1016\/j.antiviral.2008.01.003_bib33","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1073\/pnas.0402486101","article-title":"Inhibition of influenza virus production in virus-infected mice by RNA interference","volume":"101","author":"Ge","year":"2004","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.antiviral.2008.01.003_bib34","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/AAC.00644-06","article-title":"Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers","volume":"50","author":"Ge","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib35","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1371\/journal.pmed.0040091","article-title":"Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?","volume":"4","author":"Gillim-Ross","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jac\/dki405","article-title":"Treating HCV with ribavirin analogues and ribavirin-like molecules","volume":"57","author":"Gish","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virusres.2007.01.011","article-title":"Effective replication of human influenza viruses in mice lacking a major \u03b12,6 sialyltransferase","volume":"126","author":"Glaser","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib38","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/AAC.48.12.4855-4863.2004","article-title":"Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells","volume":"48","author":"Govorkova","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib39","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/AAC.01312-06","article-title":"Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus","volume":"51","author":"Govorkova","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib40","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.45.10.2723-2732.2001","article-title":"Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses","volume":"45","author":"Govorkova","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib41","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib42","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1128\/AAC.45.12.3403-3408.2001","article-title":"Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants","volume":"45","author":"Gubareva","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1465-9921-7-126","article-title":"Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice","volume":"7","author":"Hanson","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp068030","article-title":"Antiviral resistance in influenza viruses\u2014implications for management and pandemic response","volume":"354","author":"Hayden","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib45","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group","volume":"337","author":"Hayden","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib46","series-title":"Clinical Virology","first-page":"891","article-title":"Influenza virus","author":"Hayden","year":"2002"},{"key":"10.1016\/j.antiviral.2008.01.003_bib47","first-page":"51","article-title":"Intravenous ribavirin by constant infusion for serious influenza and parainfluenza virus infection","volume":"1","author":"Hayden","year":"1996","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2008.01.003_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2007.08.007","article-title":"Amantadine resistance among H5N1 avian influenza viruses isolated in Northern China","volume":"77","author":"He","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0166-3542(01)00214-5","article-title":"Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets","volume":"54","author":"Herlocher","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib50","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1086\/424572","article-title":"Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets","volume":"190","author":"Herlocher","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib51","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0960-894X(02)00329-3","article-title":"Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir","volume":"12","author":"Honda","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2008.01.003_bib52","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1128\/JVI.02677-05","article-title":"Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells","volume":"80","author":"Ibricevic","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2006.01.012","article-title":"Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant variants","volume":"70","author":"Ilyushina","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice","volume":"12","author":"Ilyushina","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2008.01.003_bib55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/135965350300800301","article-title":"Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza","volume":"8","author":"Ison","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2008.01.003_bib56","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/500465","article-title":"Recovery of drug-resistant influenza virus from immunocompromised patients: a case series","volume":"193","author":"Ison","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(06)67970-1","article-title":"Antivirals for influenza in healthy adults: systematic review","volume":"367","author":"Jefferson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib58","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","article-title":"Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations","volume":"163","author":"Kaiser","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0891-5520(20)30119-7","article-title":"Ribavirin aerosol treatment of influenza","volume":"1","author":"Knight","year":"1987","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.antiviral.2008.01.003_bib61","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(04)15589-X","article-title":"Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands","volume":"363","author":"Koopmans","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib62","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.003_bib63","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/520101","article-title":"Duration of influenza A virus shedding in hospitalized patients and implications for infection control","volume":"28","author":"Leekha","year":"2007","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2008.01.004","article-title":"Molecular strategies to inhibit the replication of RNA viruses","volume":"78","author":"Leyssen","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature02746","article-title":"Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia","volume":"430","author":"Li","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.003_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-7-43","article-title":"Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab\u2032)2 in mice","volume":"7","author":"Lu","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib67","first-page":"599","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann","volume":"145","author":"Luke","year":"2006","journal-title":"Intern. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib68","doi-asserted-by":"crossref","first-page":"20949","DOI":"10.1073\/pnas.0710286104","article-title":"Identification of H2N3 influenza A viruses from swine in the United States","volume":"104","author":"Ma","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.003_bib69","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/jm040891b","article-title":"Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza","volume":"48","author":"Macdonald","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.003_bib70","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1128\/AAC.48.12.4542-4549.2004","article-title":"Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen","volume":"48","author":"Macdonald","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib71","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1128\/JVI.79.18.11788-11800.2005","article-title":"Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals","volume":"79","author":"Maines","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib72","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib73","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0960-894X(02)01039-9","article-title":"Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir","volume":"13","author":"Masuda","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2008.01.003_bib74","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","article-title":"Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium","volume":"78","author":"Matrosovich","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib75","doi-asserted-by":"crossref","DOI":"10.1086\/523584","article-title":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada","volume":"45","author":"McGeer","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib76","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/135965350701200401","article-title":"Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus","volume":"12","author":"Medeiros","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2008.01.003_bib77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3201\/eid1201.051068","article-title":"Vaccines and antiviral drugs in pandemic preparedness","volume":"12","author":"Monto","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib78","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib79","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance\u2014disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.med.59.061506.213121","article-title":"Medical management of influenza infection","volume":"59","author":"Moscona","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib81","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1128\/JVI.77.15.8322-8328.2003","article-title":"Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice","volume":"77","author":"Mozdzanowska","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib82","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.humpath.2006.01.015","article-title":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1\u2014a review","volume":"37","author":"Ng","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nm1529","article-title":"Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract","volume":"13","author":"Nicholls","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib84","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib85","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.47.8.2518-2525.2003","article-title":"Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin","volume":"47","author":"O\u2019Keefe","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JVI.68.1.517-520.1994","article-title":"Protection against the mouse-adapted A\/FM\/1\/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains","volume":"68","author":"Okuno","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib87","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1056\/NEJMoa060601","article-title":"Avian influenza A (H5N1) infection in eastern Turkey in 2006","volume":"355","author":"Oner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib88","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMp058068","article-title":"Preparing for the next pandemic","volume":"352","author":"Osterholm","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib89","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/JVI.69.4.2075-2081.1995","article-title":"Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice","volume":"69","author":"Palladino","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib90","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0140-6736(99)03311-5","article-title":"Human infection with influenza H9N2","volume":"354","author":"Peiris","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib91","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2249.1998.00538.x","article-title":"Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab\u2032)2 fragments","volume":"111","author":"Ramisse","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3476(94)70139-3","article-title":"Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial","volume":"125","author":"Rodriguez","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2008.01.003_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.003_bib94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.20051938","article-title":"The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A\/Vietnam\/1203\/04","volume":"203","author":"Salomon","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib95","doi-asserted-by":"crossref","first-page":"12479","DOI":"10.1073\/pnas.0705289104","article-title":"Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection","volume":"104","author":"Salomon","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.003_bib96","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib97","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.inf.0000180976.81055.ce","article-title":"Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors","volume":"24","author":"Sato","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2008.01.003_bib98","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(06)70684-3","article-title":"WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus","volume":"7","author":"Schunemann","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib99","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nm757","article-title":"Lethal H5N1 influenza viruses escape host anti-viral cytokine responses","volume":"8","author":"Seo","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib100","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.296.13.1585-b","article-title":"Shift shown in influenza A adamantane resistance","volume":"296","author":"Shah","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2008.01.003_bib101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/440435a","article-title":"Avian flu: influenza virus receptors in the human airway","volume":"440","author":"Shinya","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.003_bib102","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1128\/JVI.79.15.9926-9932.2005","article-title":"Characterization of a human H5N1 influenza A virus isolated in 2003","volume":"79","author":"Shinya","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib103","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2005.06.003","article-title":"In vitro and in vivo influenza virus-inhibitory effects of viramidine","volume":"68","author":"Sidwell","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib104","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib105","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1371\/journal.pmed.0040178","article-title":"Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza","volume":"4","author":"Simmons","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2008.01.003_bib106","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/infdis\/141.5.548","article-title":"Lack of effect of oral ribavirin in naturally occurring influenza A virus infection","volume":"141","author":"Smith","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib107","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/AAC.31.8.1285","article-title":"Oral ribavirin treatment of influenza A and B","volume":"31","author":"Stein","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib108","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/glycob\/10.7.649","article-title":"Influenza virus infection of desialylated cells","volume":"10","author":"Stray","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.antiviral.2008.01.003_bib109","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.46.4.996-1004.2002","article-title":"Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection","volume":"46","author":"Sweet","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib110","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1128\/JVI.02336-06","article-title":"Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice","volume":"81","author":"Szretter","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/095632020301400502","article-title":"In vitro and in vivo activities of T-705 and oseltamivir against influenza virus","volume":"14","author":"Takahashi","year":"2003","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib112","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N","article-title":"Pathology of fatal human infection associated with avian influenza A H5N1 virus","volume":"63","author":"To","year":"2001","journal-title":"J. Med. Virol."},{"issue":"23","key":"10.1016\/j.antiviral.2008.01.003_bib113","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1073\/pnas.0402630101","article-title":"Protection against lethal influenza virus challenge by RNA interference in vivo","volume":"101","author":"Tompkins","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.003_bib114","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2008.01.003_bib115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.39105.428981.BE","article-title":"Role of combination antiviral therapy in pandemic influenza","volume":"334","author":"Tsiodras","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2008.01.003_bib116","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3201\/eid1012.040961","article-title":"Human illness from avian influenza H7N3, British Columbia","volume":"10","author":"Tweed","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib117","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3201\/eid1107.041313","article-title":"Influenza A H5N1 replication sites in humans","volume":"11","author":"Uiprasertkul","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib118","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1125548","article-title":"H5N1 virus attachment to lower respiratory tract","volume":"312","author":"van Riel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.01.003_bib119","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/rmv.352","article-title":"Functional balance between haemagglutinin and neuraminidase in influenza virus infections","volume":"12","author":"Wagner","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib120","unstructured":"World Health Organization, 2006. Advice on use of oseltamivir."},{"key":"10.1016\/j.antiviral.2008.01.003_bib121","unstructured":"World Health Organization, 2007. Cumulative number of confirmed human cases of avian influenza A\/(H5N1) reported to WHO, vol. 2007, no. August 15."},{"key":"10.1016\/j.antiviral.2008.01.003_bib122","series-title":"Fields Virology","first-page":"1533","article-title":"Orthomyxoviruses","author":"Wright","year":"2001"},{"issue":"2","key":"10.1016\/j.antiviral.2008.01.003_bib123","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbrc.2007.10.196","article-title":"Inhibition of highly pathogenic avian H5N1 influenza virus replication by RNA oligonucleotides targeting NS1 gene","volume":"365","author":"Wu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2008.01.003_bib124","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.49.10.4075-4084.2005","article-title":"Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility","volume":"49","author":"Yen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.003_bib125","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1128\/JVI.00477-06","article-title":"Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses","volume":"80","author":"Yen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib126","doi-asserted-by":"crossref","first-page":"12418","DOI":"10.1128\/JVI.01067-07","article-title":"Neuraminidase inhibitor-resistant recombinant A\/Vietnam\/1203\/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo","volume":"81","author":"Yen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.003_bib127","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/432008","article-title":"Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A\/Vietnam\/1203\/04 influenza virus in mice","volume":"192","author":"Yen","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.003_bib128","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(98)01182-9","article-title":"Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus","volume":"351","author":"Yuen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.003_bib129","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection.","volume":"357","author":"Zhou","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.antiviral.2008.01.003_bib130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2007.07.002","article-title":"Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice","volume":"76","author":"Zhou","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.003_bib131","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/dkl321","article-title":"Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro","volume":"58","author":"Z\u00fcrcher","year":"2006","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T18:47:11Z","timestamp":1737917231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0166354208000235"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}